When is it a good time to purchase CRM?

**Salesforce's (CRM) current market conditions suggest a cautious approach**, and the decision to buy should be aligned with a clear understanding of the company's growth prospects and risk factors. Here are key considerations: 1. **Technical Indicators Suggest Caution**: - The stock is trading below both the 20-day and 50-day moving averages, indicating a bearish trend. - The MACD is negative, the RSI is neutral at 38.36, and the KDJ indicator is at 23.1, suggesting the stock might be oversold. - Support is seen at the $226.48 level, and resistance at $258. |code|Ticker|Name|Date|Support Level|Resistance Level|market_code| |---|---|---|---|---|---|---| |CRM|CRM.N|Salesforce|20250915|226.4800|258.0000|169| |code|Ticker|Name|Date|Closing Price|market_code| |---|---|---|---|---|---| |CRM|CRM.N|Salesforce|20250102|330.66|169| |CRM|CRM.N|Salesforce|20250103|332.9|169| |CRM|CRM.N|Salesforce|20250106|330.53|169| |CRM|CRM.N|Salesforce|20250107|324.93|169| |CRM|CRM.N|Salesforce|20250108|326.9|169| |CRM|CRM.N|Salesforce|20250110|317.85|169| |CRM|CRM.N|Salesforce|20250113|319.07|169| |CRM|CRM.N|Salesforce|20250114|323.54|169| |CRM|CRM.N|Salesforce|20250115|321.16|169| |CRM|CRM.N|Salesforce|20250116|320|169| |code|Ticker|Name|Date|Moving Average|market_code| |---|---|---|---|---|---| |CRM|CRM.N|Salesforce|20250912|247.1880|169| |code|Ticker|Name|Date|Boll|RSI|KDJ|MACD|market_code| |---|---|---|---|---|---|---|---|---| |CRM|CRM.N|Salesforce|20250912|248.2775|38.7774|28.1008|-0.3318|169| 2. **Market Sentiment and Insider Activity**: - Recent insider purchases, such as David B. Kirk's $865,827 investment, demonstrate confidence in the company's growth potential. - However, Salesforce's stock fell 7% following Q2 guidance that fell below expectations, raising questions about the sustainability of its AI-driven growth. 3. **Financial Health and Growth Prospects**: - Salesforce has a strong financial health with a P/E ratio of 34.69, a P/S ratio of 5.85, and a P/B ratio of 3.76. - The company reported a 9.8% year-over-year revenue growth and a 11.4% increase in cRPO, indicating strong growth potential. - Salesforce's partnership with Pearson for certification exams and its AI initiatives, such as Agentforce, highlight its commitment to innovation. 4. **Valuation Metrics and Analyst Targets**: - The stock's P/E ratio is close to its 10-year low, and the P/S ratio is near a 2-year low, suggesting a potentially undervalued position. - Analyst targets, such as Keith Bachman's prediction of $332.58, indicate potential upside from current levels. In conclusion, while Salesforce's strategic initiatives and financial health are positive signs, the current technical indicators and market sentiment suggest a good time to purchase CRM may be when the stock is trading around support levels or when there is a clear upward momentum in the market. Investors should also consider their investment horizon, risk tolerance, and the potential alignment with Salesforce's growth strategy.